<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>GIDS Research Radar · Plasmodium vivax malaria</title>
  <link>https://globalinfectiousdisease.com/research/</link>
  <description>Published infectious-disease literature filtered to Plasmodium vivax malaria.</description>
  <language>en</language>
  <atom:link href="https://globalinfectiousdisease.com/research/rss/diseases/plasmodium-vivax-malaria.xml" rel="self" type="application/rss+xml" />
  <lastBuildDate>Wed, 09 Sep 2026 07:02:01 GMT</lastBuildDate>
  <item>
    <title>Delayed diagnosis of Plasmodium vivax malaria and associated factors among Thai patients and patients from neighboring countries at the Hospital for Tropical Diseases, Bangkok, Thailand</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1007-s15010-026-02930-8-9d04ab14/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1007-s15010-026-02930-8-9d04ab14/</guid>
    <pubDate>Mon, 17 Aug 2026 00:00:00 GMT</pubDate>
    <description>Recognizing these temporal barriers supports the development of region-specific awareness campaigns and triage guidelines for fever management in areas experiencing reduced transmission.</description>
    <category>Plasmodium vivax malaria</category>
    <category>Malaria</category>
    <category>Diagnostics</category>
    <category>Travel medicine</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Evaluation of immunogenicity and efficacy of a Plasmodium vivax nanoparticle vaccine in mice</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128857-f9db4a24/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128857-f9db4a24/</guid>
    <pubDate>Sat, 01 Aug 2026 00:00:00 GMT</pubDate>
    <description>The adaptable architecture of this delivery mechanism supports future development of combined immunizations targeting multiple vivax malaria components, aligning with broader disease control objectives.</description>
    <category>Malaria</category>
    <category>Plasmodium vivax malaria</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Transmission dynamics</category>
    <category>Journal article</category>
  </item>
</channel>
</rss>
